New skin cell-based injectable solution aims to improve breast reconstruction outcomes

A group of scientists found a way to reduce the need for reconstructive surgery after tumor removal for breast cancer patients, according to the American Chemical Society (ACS).

The new method includes an “injectable paste derived from human skin cells” aimed at reinstating breast volume. The paste is said to be safer and reduce scarring and healing time compared to current methods. It is an acellular dermal matrix (ADM) that can be injected. The new method is not currently for clinical use, but the researchers aim for more trials to be conducted.